nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Disulfiram—alcohol dependence	0.367	0.584	CbGbCtD
Fosamprenavir—CYP3A4—Citalopram—alcohol dependence	0.262	0.416	CbGbCtD
Fosamprenavir—Loose stools—Naltrexone—alcohol dependence	0.011	0.0347	CcSEcCtD
Fosamprenavir—Calculus of kidney—Acamprosate—alcohol dependence	0.00981	0.031	CcSEcCtD
Fosamprenavir—Blood cholesterol increased—Citalopram—alcohol dependence	0.00957	0.0302	CcSEcCtD
Fosamprenavir—Nephrolithiasis—Acamprosate—alcohol dependence	0.008	0.0253	CcSEcCtD
Fosamprenavir—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00766	0.141	CbGpPWpGaD
Fosamprenavir—Gastrooesophageal reflux disease—Naltrexone—alcohol dependence	0.00674	0.0213	CcSEcCtD
Fosamprenavir—Hypercholesterolaemia—Naltrexone—alcohol dependence	0.00643	0.0203	CcSEcCtD
Fosamprenavir—Breast enlargement—Citalopram—alcohol dependence	0.00594	0.0188	CcSEcCtD
Fosamprenavir—Calculus of kidney—Citalopram—alcohol dependence	0.00588	0.0186	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Acamprosate—alcohol dependence	0.00537	0.017	CcSEcCtD
Fosamprenavir—Hyperlipidaemia—Citalopram—alcohol dependence	0.00535	0.0169	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.0049	0.0901	CbGpPWpGaD
Fosamprenavir—Nephrolithiasis—Citalopram—alcohol dependence	0.0048	0.0152	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Citalopram—alcohol dependence	0.00436	0.0138	CcSEcCtD
Fosamprenavir—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00427	0.0135	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.0042	0.0133	CcSEcCtD
Fosamprenavir—Gastritis—Acamprosate—alcohol dependence	0.00413	0.0131	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00412	0.013	CcSEcCtD
Fosamprenavir—Hypercholesterolaemia—Citalopram—alcohol dependence	0.00408	0.0129	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00406	0.0747	CbGpPWpGaD
Fosamprenavir—Fatigue—Disulfiram—alcohol dependence	0.00402	0.0127	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00398	0.0126	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.0039	0.0123	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Acamprosate—alcohol dependence	0.00364	0.0115	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00355	0.0112	CcSEcCtD
Fosamprenavir—Myocardial infarction—Acamprosate—alcohol dependence	0.00353	0.0111	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00346	0.0635	CbGpPWpGaD
Fosamprenavir—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00335	0.0106	CcSEcCtD
Fosamprenavir—Asthenia—Disulfiram—alcohol dependence	0.00334	0.0106	CcSEcCtD
Fosamprenavir—Myocardial infarction—Naltrexone—alcohol dependence	0.00334	0.0105	CcSEcCtD
Fosamprenavir—Haemoglobin—Acamprosate—alcohol dependence	0.00325	0.0103	CcSEcCtD
Fosamprenavir—Haemorrhage—Acamprosate—alcohol dependence	0.00323	0.0102	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Citalopram—alcohol dependence	0.00322	0.0102	CcSEcCtD
Fosamprenavir—Dizziness—Disulfiram—alcohol dependence	0.00308	0.00973	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Naltrexone—alcohol dependence	0.003	0.00949	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00294	0.054	CbGpPWpGaD
Fosamprenavir—Rash—Disulfiram—alcohol dependence	0.00294	0.00928	CcSEcCtD
Fosamprenavir—Headache—Disulfiram—alcohol dependence	0.00292	0.00922	CcSEcCtD
Fosamprenavir—Immune system disorder—Acamprosate—alcohol dependence	0.00292	0.00921	CcSEcCtD
Fosamprenavir—Cardiac disorder—Naltrexone—alcohol dependence	0.00284	0.00896	CcSEcCtD
Fosamprenavir—Malnutrition—Acamprosate—alcohol dependence	0.00281	0.00888	CcSEcCtD
Fosamprenavir—Flatulence—Acamprosate—alcohol dependence	0.00277	0.00875	CcSEcCtD
Fosamprenavir—Immune system disorder—Naltrexone—alcohol dependence	0.00276	0.00872	CcSEcCtD
Fosamprenavir—Malnutrition—Naltrexone—alcohol dependence	0.00266	0.0084	CcSEcCtD
Fosamprenavir—Flatulence—Naltrexone—alcohol dependence	0.00262	0.00828	CcSEcCtD
Fosamprenavir—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00258	0.0475	CbGpPWpGaD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00258	0.0473	CbGpPWpGaD
Fosamprenavir—Angioedema—Acamprosate—alcohol dependence	0.00257	0.00811	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00252	0.00796	CcSEcCtD
Fosamprenavir—Gastritis—Citalopram—alcohol dependence	0.00248	0.00782	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00247	0.0078	CcSEcCtD
Fosamprenavir—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00245	0.0451	CbGpPWpGaD
Fosamprenavir—Angioedema—Naltrexone—alcohol dependence	0.00243	0.00768	CcSEcCtD
Fosamprenavir—Myalgia—Acamprosate—alcohol dependence	0.00239	0.00756	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00238	0.00751	CcSEcCtD
Fosamprenavir—Myalgia—Naltrexone—alcohol dependence	0.00226	0.00715	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00225	0.0071	CcSEcCtD
Fosamprenavir—Skin disorder—Acamprosate—alcohol dependence	0.00223	0.00704	CcSEcCtD
Fosamprenavir—Anorexia—Acamprosate—alcohol dependence	0.00219	0.00691	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Citalopram—alcohol dependence	0.00218	0.00689	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.00214	0.00675	CcSEcCtD
Fosamprenavir—Nervous system disorder—Naltrexone—alcohol dependence	0.00213	0.00673	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Citalopram—alcohol dependence	0.00213	0.00672	CcSEcCtD
Fosamprenavir—Myocardial infarction—Citalopram—alcohol dependence	0.00211	0.00668	CcSEcCtD
Fosamprenavir—Skin disorder—Naltrexone—alcohol dependence	0.00211	0.00666	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00209	0.0066	CcSEcCtD
Fosamprenavir—Anorexia—Naltrexone—alcohol dependence	0.00207	0.00654	CcSEcCtD
Fosamprenavir—Decreased appetite—Acamprosate—alcohol dependence	0.00199	0.0063	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00198	0.00626	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00198	0.00625	CcSEcCtD
Fosamprenavir—Haemoglobin—Citalopram—alcohol dependence	0.00195	0.00615	CcSEcCtD
Fosamprenavir—Haemorrhage—Citalopram—alcohol dependence	0.00194	0.00612	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Citalopram—alcohol dependence	0.00191	0.00604	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Citalopram—alcohol dependence	0.0019	0.00601	CcSEcCtD
Fosamprenavir—Urethral disorder—Citalopram—alcohol dependence	0.0019	0.006	CcSEcCtD
Fosamprenavir—Decreased appetite—Naltrexone—alcohol dependence	0.00189	0.00596	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00188	0.00593	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00187	0.00592	CcSEcCtD
Fosamprenavir—Fatigue—Naltrexone—alcohol dependence	0.00187	0.00591	CcSEcCtD
Fosamprenavir—Erythema multiforme—Citalopram—alcohol dependence	0.00183	0.00578	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00181	0.0334	CbGpPWpGaD
Fosamprenavir—Abdominal pain—Acamprosate—alcohol dependence	0.00181	0.00573	CcSEcCtD
Fosamprenavir—Body temperature increased—Acamprosate—alcohol dependence	0.00181	0.00573	CcSEcCtD
Fosamprenavir—Cardiac disorder—Citalopram—alcohol dependence	0.0018	0.00568	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00177	0.00561	CcSEcCtD
Fosamprenavir—Immune system disorder—Citalopram—alcohol dependence	0.00175	0.00552	CcSEcCtD
Fosamprenavir—Abdominal pain—Naltrexone—alcohol dependence	0.00172	0.00542	CcSEcCtD
Fosamprenavir—Body temperature increased—Naltrexone—alcohol dependence	0.00172	0.00542	CcSEcCtD
Fosamprenavir—Hypersensitivity—Acamprosate—alcohol dependence	0.00169	0.00534	CcSEcCtD
Fosamprenavir—Malnutrition—Citalopram—alcohol dependence	0.00169	0.00532	CcSEcCtD
Fosamprenavir—Flatulence—Citalopram—alcohol dependence	0.00166	0.00525	CcSEcCtD
Fosamprenavir—Asthenia—Acamprosate—alcohol dependence	0.00165	0.0052	CcSEcCtD
Fosamprenavir—Pruritus—Acamprosate—alcohol dependence	0.00162	0.00513	CcSEcCtD
Fosamprenavir—Hypersensitivity—Naltrexone—alcohol dependence	0.0016	0.00505	CcSEcCtD
Fosamprenavir—Diarrhoea—Acamprosate—alcohol dependence	0.00157	0.00496	CcSEcCtD
Fosamprenavir—Asthenia—Naltrexone—alcohol dependence	0.00156	0.00492	CcSEcCtD
Fosamprenavir—Angioedema—Citalopram—alcohol dependence	0.00154	0.00486	CcSEcCtD
Fosamprenavir—Pruritus—Naltrexone—alcohol dependence	0.00154	0.00485	CcSEcCtD
Fosamprenavir—Dizziness—Acamprosate—alcohol dependence	0.00152	0.00479	CcSEcCtD
Fosamprenavir—Diarrhoea—Naltrexone—alcohol dependence	0.00149	0.00469	CcSEcCtD
Fosamprenavir—Vomiting—Acamprosate—alcohol dependence	0.00146	0.00461	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00145	0.0267	CbGpPWpGaD
Fosamprenavir—Rash—Acamprosate—alcohol dependence	0.00145	0.00457	CcSEcCtD
Fosamprenavir—Dermatitis—Acamprosate—alcohol dependence	0.00145	0.00457	CcSEcCtD
Fosamprenavir—Headache—Acamprosate—alcohol dependence	0.00144	0.00454	CcSEcCtD
Fosamprenavir—Dizziness—Naltrexone—alcohol dependence	0.00144	0.00453	CcSEcCtD
Fosamprenavir—Myalgia—Citalopram—alcohol dependence	0.00143	0.00453	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00142	0.0045	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00138	0.0254	CbGpPWpGaD
Fosamprenavir—Vomiting—Naltrexone—alcohol dependence	0.00138	0.00436	CcSEcCtD
Fosamprenavir—Rash—Naltrexone—alcohol dependence	0.00137	0.00432	CcSEcCtD
Fosamprenavir—Dermatitis—Naltrexone—alcohol dependence	0.00137	0.00432	CcSEcCtD
Fosamprenavir—Nausea—Acamprosate—alcohol dependence	0.00136	0.00431	CcSEcCtD
Fosamprenavir—Headache—Naltrexone—alcohol dependence	0.00136	0.0043	CcSEcCtD
Fosamprenavir—Nervous system disorder—Citalopram—alcohol dependence	0.00135	0.00426	CcSEcCtD
Fosamprenavir—Skin disorder—Citalopram—alcohol dependence	0.00134	0.00422	CcSEcCtD
Fosamprenavir—Anorexia—Citalopram—alcohol dependence	0.00131	0.00414	CcSEcCtD
Fosamprenavir—Nausea—Naltrexone—alcohol dependence	0.00129	0.00407	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00125	0.00396	CcSEcCtD
Fosamprenavir—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.00121	0.0223	CbGpPWpGaD
Fosamprenavir—Decreased appetite—Citalopram—alcohol dependence	0.0012	0.00378	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00119	0.00375	CcSEcCtD
Fosamprenavir—Fatigue—Citalopram—alcohol dependence	0.00119	0.00375	CcSEcCtD
Fosamprenavir—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00117	0.0214	CbGpPWpGaD
Fosamprenavir—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00116	0.0213	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00114	0.021	CbGpPWpGaD
Fosamprenavir—Gastrointestinal pain—Citalopram—alcohol dependence	0.00112	0.00355	CcSEcCtD
Fosamprenavir—Abdominal pain—Citalopram—alcohol dependence	0.00109	0.00343	CcSEcCtD
Fosamprenavir—Body temperature increased—Citalopram—alcohol dependence	0.00109	0.00343	CcSEcCtD
Fosamprenavir—Hypersensitivity—Citalopram—alcohol dependence	0.00101	0.0032	CcSEcCtD
Fosamprenavir—Asthenia—Citalopram—alcohol dependence	0.000987	0.00312	CcSEcCtD
Fosamprenavir—Pruritus—Citalopram—alcohol dependence	0.000973	0.00307	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000973	0.0179	CbGpPWpGaD
Fosamprenavir—Diarrhoea—Citalopram—alcohol dependence	0.000941	0.00297	CcSEcCtD
Fosamprenavir—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000917	0.0169	CbGpPWpGaD
Fosamprenavir—Dizziness—Citalopram—alcohol dependence	0.000909	0.00287	CcSEcCtD
Fosamprenavir—Vomiting—Citalopram—alcohol dependence	0.000874	0.00276	CcSEcCtD
Fosamprenavir—Rash—Citalopram—alcohol dependence	0.000867	0.00274	CcSEcCtD
Fosamprenavir—Dermatitis—Citalopram—alcohol dependence	0.000866	0.00274	CcSEcCtD
Fosamprenavir—Headache—Citalopram—alcohol dependence	0.000862	0.00272	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000827	0.0152	CbGpPWpGaD
Fosamprenavir—Nausea—Citalopram—alcohol dependence	0.000817	0.00258	CcSEcCtD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000794	0.0146	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.00078	0.0143	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000734	0.0135	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000725	0.0133	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000623	0.0115	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000608	0.0112	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000601	0.011	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000517	0.0095	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000511	0.00939	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000504	0.00926	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000497	0.00914	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000439	0.00807	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000421	0.00774	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000409	0.00751	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000385	0.00708	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000336	0.00618	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000319	0.00587	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000271	0.00499	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00027	0.00496	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000219	0.00402	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000217	0.00399	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000214	0.00393	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000199	0.00366	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000179	0.00328	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADH6—alcohol dependence	0.000125	0.00231	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—POMC—alcohol dependence	0.000116	0.00214	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADH1A—alcohol dependence	0.000104	0.00191	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADH4—alcohol dependence	8.84e-05	0.00162	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADH7—alcohol dependence	7.52e-05	0.00138	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GGT2—alcohol dependence	7.2e-05	0.00132	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADH1B—alcohol dependence	6.59e-05	0.00121	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—MAOB—alcohol dependence	5.46e-05	0.001	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALDH2—alcohol dependence	4.64e-05	0.000853	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GOT2—alcohol dependence	3.95e-05	0.000725	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.71e-05	0.000682	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GGT1—alcohol dependence	3.41e-05	0.000626	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GOT1—alcohol dependence	3.41e-05	0.000626	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—MAOA—alcohol dependence	3.05e-05	0.000561	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—POMC—alcohol dependence	1.99e-05	0.000365	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—EP300—alcohol dependence	1.32e-05	0.000242	CbGpPWpGaD
